Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 1:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 13,929 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Catheter-related Bloodstream Infection
Interventions: SQ53 Wipe, Ethanol Wipe; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Contraception
Interventions: FemBloc, Laparoscopic bilateral tubal sterilization; Device · Procedure
Lead sponsor: Femasys Inc.; Industry
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 12
States / cities: Chandler, Arizona • Stanford, California • Lake Worth, Florida + 9 more

Conditions: Scleroderma, Raynaud's Syndrome
Interventions: Onabotulinumtoxin A, sterile saline solution; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Rotator Cuff Tear
Interventions: Rotator cuff repair, Ibuprofen, Hydrocodone/Acetaminophen, Omeprazole, Hydrocodone/Acetaminophen; Procedure · Drug
Lead sponsor: University of Chicago; Other
Eligibility: 45 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colorectal Cancer Screening
Interventions: Short animated storytelling video; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 45 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Idiopathic Hypersomnia
Interventions: TAK-360, Placebo; Drug · Other
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 13
States / cities: Redwood City, California • Santa Ana, California • Colorado Springs, Colorado + 9 more

Conditions: COPD
Interventions: PEP Buddy, PEP Buddy Sham; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 89 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Cincinnati, Ohio • Cleveland, Ohio

Conditions: Headache, Migraine, Tension Headache, Occipital Neuralgia
Interventions: 0.5% Bupivacaine HCl, standard IV treatment for headache; Drug
Lead sponsor: HCA Florida North Florida Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Labor Stage, First, Prolonged Labor
Interventions: Circuit of maternal position changes during labor; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years and older · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Infertility, Female
Interventions: FET Protocol; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 53 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Basking Ridge, New Jersey • Marlton, New Jersey

Conditions: Obesity
Interventions: Hybrid Argon Plasma Coagulation, Endoscopic Sleeve Gastroplasty; Procedure
Lead sponsor: True You Weight Loss; Other
Eligibility: 21 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cary, North Carolina

Conditions: Excessive Bleeding During Surgery
Interventions: Hemoblast Bellows application; Drug
Lead sponsor: WakeMed Health and Hospitals; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Chronic Kidney Disease, Type 2 Diabetes
Interventions: Finerenone, Semaglutide, Lotensin, Capoten, Enalapril, Monopril, Lisinopril, Univasc, Aceon, Accupril, Altace, Mavik, Edarbi, Atacand, Avapro, Cozaar, Benicar, Micardis, Diovan, Invokana, Farxiga, Jardiance, Ertugliflozin, Brenzavvy, Sotagliflozin; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 84 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Seasonal Allergic Rhinitis
Interventions: 0.15% azelastine hydrochloride 1644 mcg daily, 0.1% azelastine hydrochloride 1096 mcg daily, Placebo; Drug
Lead sponsor: Meda Pharmaceuticals; Industry
Eligibility: 12 Years and older
Enrollment: 526 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 29
States / cities: Oxford, Alabama • Encinitas, California • Los Angeles, California + 25 more

Conditions: Systemic Scleroderma, Pulmonary Hypertension
Interventions: Bosentan, Placebo; Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Farmington, Connecticut • Washington D.C., District of Columbia

Conditions: Head and Neck Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma, Oral Cavity Carcinoma, Oropharyngeal Carcinoma
Interventions: Electronic Health Record Review, Fentanyl, Laryngoscopy, Methadone, Surgical Procedure, Survey Administration; Other · Drug · Device + 1 more
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Osteoarthritis
Interventions: Supartz, Euflexxa; Device
Lead sponsor: Bioventus LLC; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 421 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bronchiolitis
Interventions: 3% sodium chloride, 0.9% sodium chloride; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: Up to 12 Months
Enrollment: 227 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Biliary Diseases, Pancreatic Duct Disorder
Interventions: Exalt Model D, Reusable; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 19 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Sjogrens Disease
Interventions: Efgartigimod PH20 SC, Placebo PH20 SC; Biological · Other
Lead sponsor: argenx; Industry
Eligibility: 18 Years and older
Enrollment: 631 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 42
States / cities: Scottsdale, Arizona • Sun City, Arizona • Tucson, Arizona + 36 more

Conditions: Substance Abuse, Substance Use Disorders, Prevention, Legislation, Use of Research Evidence
Interventions: Intervention: RPC Group, Active Comparator: Control Group; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Cognitive Abilities, Performance, Stress, Cognitive Performance
Interventions: EEG-guided binaural beat audio, Non-binaural audio intervention; Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Hypertension, Reproductive Behavior, Primary Health Care, Electronic Health Record
Interventions: Health literacy-informed patient education materials, BP monitor, brief orientation, and portal tools, The MeDS assessment, Patient navigator support; Other · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Alcohol Dependence
Interventions: Acamprosate (Campral); Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Milwaukee, Wisconsin

Search by objective public record fields.

SQ53 Disinfectant Wipes for Prevention of CRBSI

FemBloc® Permanent Contraception - Early Pivotal Trial

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

The Effect of NSAIDs After a Rotator Cuff Repair Surgery.

Animated Storytelling to Promote Colorectal Cancer Screening

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

PEP Buddy in Pulmonary Rehabilitation

0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment

Maternal Maneuvers During Prolonged Labor

PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study

sTErnAl heMostasiS Trial

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers

Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA

A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis

Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts

EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition

The REACH-OUT Trial

Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic